{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:14:04Z","timestamp":1791335644337,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072577"],"award-info":[{"award-number":["82072577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04012-4","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T10:54:35Z","timestamp":1743159275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma"],"prefix":"10.1007","volume":"74","author":[{"given":"Huilin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanxue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"Suppl 1","key":"4012_CR1","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","volume":"9","author":"N Alpert","year":"2020","unstructured":"Alpert N, van Gerwen M, Taioli E (2020) Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40\u00a0years after restricted\/banned asbestos use. Transl Lung Cancer Res 9(Suppl 1):S28\u2013S38","journal-title":"Transl Lung Cancer Res"},{"key":"4012_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103821","volume":"179","author":"Y Han","year":"2022","unstructured":"Han Y, Zhang T, Chen H, Yang X (2022) Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Crit Rev Oncol Hematol 179:103821","journal-title":"Crit Rev Oncol Hematol"},{"key":"4012_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2024.124928","volume":"362","author":"L Feng","year":"2024","unstructured":"Feng L, Li T, Xu B, Huang J, Xia H, Jiang Z, Chen J, Pan S, Zhang X, Jiang H et al (2024) Integrated DNA methylation analysis of peripheral blood from asbestos exposed populations and patients with malignant mesothelioma reveals novel methylation driver genes of diagnostic and prognostic relevance. Environ Pollut 362:124928","journal-title":"Environ Pollut"},{"issue":"19","key":"4012_CR4","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.3390\/jcm13195837","volume":"13","author":"M Jain","year":"2024","unstructured":"Jain M, Crites MK, Rich P, Bajantri B (2024) Malignant pleural mesothelioma: a comprehensive review. J Clin Med 13(19):5837","journal-title":"J Clin Med"},{"issue":"4","key":"4012_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/PAP.0000000000000386","volume":"30","author":"CD Strange","year":"2023","unstructured":"Strange CD, Marom EM, Ahuja J, Shroff GS, Gladish GW, Carter BW, Truong MT (2023) Imaging of malignant pleural, pericardial, and peritoneal mesothelioma. Adv Anat Pathol 30(4):280\u2013291","journal-title":"Adv Anat Pathol"},{"issue":"Suppl 1","key":"4012_CR6","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","volume":"9","author":"A Greenbaum","year":"2020","unstructured":"Greenbaum A, Alexander HR (2020) Peritoneal mesothelioma. Transl Lung Cancer Res 9(Suppl 1):S120\u2013S132","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"4012_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","volume":"478","author":"MB Beasley","year":"2021","unstructured":"Beasley MB, Galateau-Salle F, Dacic S (2021) Pleural mesothelioma classification update. Virchows Arch 478(1):59\u201372","journal-title":"Virchows Arch"},{"issue":"2","key":"4012_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","volume":"33","author":"A Churg","year":"2020","unstructured":"Churg A, Galateau-Salle F, Roden AC, Attanoos R, von der Thusen JH, Tsao MS, Chang N, De Perrot M, Dacic S (2020) Malignant mesothelioma in situ: morphologic features and clinical outcome. Mod Pathol 33(2):297\u2013302","journal-title":"Mod Pathol"},{"issue":"159","key":"4012_CR9","doi-asserted-by":"publisher","first-page":"200226","DOI":"10.1183\/16000617.0226-2020","volume":"30","author":"R Asciak","year":"2021","unstructured":"Asciak R, George V, Rahman NM (2021) Update on biology and management of mesothelioma. European Respiratory Rev 30(159):200226. https:\/\/doi.org\/10.1183\/16000617.0226-2020","journal-title":"European Respiratory Rev"},{"issue":"Suppl 1","key":"4012_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","volume":"9","author":"DB Chapel","year":"2020","unstructured":"Chapel DB, Schulte JJ, Husain AN, Krausz T (2020) Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Transl Lung Cancer Res 9(Suppl 1):S3\u2013S27","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"4012_CR11","doi-asserted-by":"publisher","first-page":"100706","DOI":"10.1016\/j.modpat.2025.100706","volume":"38","author":"RE Fanaroff","year":"2025","unstructured":"Fanaroff RE, Yang S-R, Tan KS, Adusumilli PS, Bodd F, Bowman A, Chang J, Offin MD, Reiner A, Rekhtman N, Rusch VW, Travis WD, Zauderer MG, Ladanyi M, Sauter JL (2025) Correlation of Histologic features with gene alterations in pleural mesothelioma. Mod Pathol 38(5):100706. https:\/\/doi.org\/10.1016\/j.modpat.2025.100706","journal-title":"Mod Pathol"},{"issue":"4","key":"4012_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.21037\/tlcr-24-28","volume":"13","author":"N Alnassar","year":"2024","unstructured":"Alnassar N, Derry JMJ, Banna GL, Gorecki DC (2024) Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas. Transl Lung Cancer Res 13(4):733\u2013748","journal-title":"Transl Lung Cancer Res"},{"issue":"12","key":"4012_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00262-024-03815-1","volume":"73","author":"K Sakura","year":"2024","unstructured":"Sakura K, Kuroyama M, Shintani Y, Funaki S, Atagi S, Kadota Y, Kuribayashi K, Kijima T, Nakano T, Nakajima T et al (2024) Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial. Cancer Immunol Immunother 73(12):243","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"4012_CR14","first-page":"1078","volume":"21","author":"H Wu","year":"2024","unstructured":"Wu H, Wang Y, Lin Y, Ma R, Du X, Su Y, Yang R, Yang Z, Liang X, Zhang Y et al (2024) Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy. Cancer Biol Med 21(11):1078\u20131094","journal-title":"Cancer Biol Med"},{"key":"4012_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112039","volume":"133","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Sun N, Liu W (2024) High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma. Int Immunopharmacol 133:112039","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"4012_CR16","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1111\/cas.14523","volume":"111","author":"D Horio","year":"2020","unstructured":"Horio D, Minami T, Kitai H, Ishigaki H, Higashiguchi Y, Kondo N, Hirota S, Kitajima K, Nakajima Y, Koda Y et al (2020) Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma. Cancer Sci 111(8):2895\u20132906","journal-title":"Cancer Sci"},{"issue":"3","key":"4012_CR17","doi-asserted-by":"publisher","first-page":"e004115","DOI":"10.1136\/jitc-2021-004115","volume":"10","author":"T Michelakos","year":"2022","unstructured":"Michelakos T, Kontos F, Kurokawa T, Cai L, Sadagopan A, Krijgsman D, Weichert W, Durrant LG, Kuppen PJK, Ferrone CR, Ferrone S (2022) Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer. J ImmunoTherapy Cancer 10(3):e004115. https:\/\/doi.org\/10.1136\/jitc-2021-004115","journal-title":"J ImmunoTherapy Cancer"},{"issue":"2","key":"4012_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13069","volume":"29","author":"E Apoorva","year":"2024","unstructured":"Apoorva E, Jacob R, Rao DN, Kumar S (2024) Helicobacter pylori enhances HLA-C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells. Helicobacter 29(2):e13069","journal-title":"Helicobacter"},{"issue":"1","key":"4012_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12864-022-08509-5","volume":"23","author":"EB Lim","year":"2022","unstructured":"Lim EB, Oh HS, Kim KC, Kim MH, Kim YJ, Kim BJ, Nho CW, Cho YS (2022) Identification and functional validation of HLA-C as a potential gene involved in colorectal cancer in the Korean population. BMC Genom 23(1):261","journal-title":"BMC Genom"},{"issue":"1","key":"4012_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-024-00646-3","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Zuo F, Song J, Tang L, Wang X, Liu X, Zhang H, Yang Z, Jing J, Ma X et al (2024) Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance. Cell Discov 10(1):16","journal-title":"Cell Discov"},{"issue":"11","key":"4012_CR21","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/cells10113108","volume":"10","author":"S Vollmers","year":"2021","unstructured":"Vollmers S, Lobermeyer A, K\u00f6rner C (2021) The new kid on the block: HLA-C, a key regulator of natural killer cells in viral immunity. Cells 10(11):3108. https:\/\/doi.org\/10.3390\/cells10113108","journal-title":"Cells"},{"issue":"1","key":"4012_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2011.03422.x","volume":"133","author":"ME Blais","year":"2011","unstructured":"Blais ME, Dong T, Rowland-Jones S (2011) HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 133(1):1\u20137","journal-title":"Immunology"},{"key":"4012_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Thomas Lumbers R, Shah T, Engmann J, Galver L, Kelley R, Karlsson A, Santos R, Overington JP, Hingorani AD, Casas JP (2017) The druggable genome and support for target identification and validation in drug development. Sci Trans Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166","journal-title":"Sci Trans Med"},{"issue":"9","key":"4012_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman AK, Kalnapenkis A, Enroth S, Cozzetto D, Digby-Bell J, Marten J et al (2023) Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol 24(9):1540\u20131551","journal-title":"Nat Immunol"},{"issue":"10","key":"4012_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orru","year":"2020","unstructured":"Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036\u20131045","journal-title":"Nat Genet"},{"issue":"1","key":"4012_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41588-023-01600-x","volume":"56","author":"M Homilius","year":"2024","unstructured":"Homilius M, Zhu W, Eddy SS, Thompson PC, Zheng H, Warren CN, Evans CG, Kim DD, Xuan LL, Nsubuga C et al (2024) Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseases. Nat Genet 56(1):37\u201350","journal-title":"Nat Genet"},{"issue":"1","key":"4012_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, Cerani A, Liang KYH, Yoshiji S, Willett JDS et al (2023) Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet 55(1):44\u201353","journal-title":"Nat Genet"},{"issue":"9","key":"4012_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210836120","volume":"120","author":"L Wu","year":"2023","unstructured":"Wu L, Kohno M, Murakami J, Zia A, Allen J, Yun H, Chan M, Baciu C, Liu M, Serre-Beinier V et al (2023) Defining and targeting tumor-associated macrophages in malignant mesothelioma. Proc Natl Acad Sci U S A 120(9):e2210836120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4012_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.trecan.2023.05.003","volume":"9","author":"MA Salkeni","year":"2023","unstructured":"Salkeni MA, Naing A (2023) Interleukin-10 in cancer immunotherapy: from bench to bedside. Trends Cancer 9(9):716\u2013725","journal-title":"Trends Cancer"},{"issue":"6","key":"4012_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccell.2022.04.018","volume":"40","author":"H Long","year":"2022","unstructured":"Long H, Jia Q, Wang L et al (2022) Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1\/PD-L1 treatment efficacy. Cancer Cell 40(6):674\u2013693","journal-title":"Cancer Cell"},{"issue":"19","key":"4012_CR31","first-page":"2343","volume":"141","author":"BJ Stewart","year":"2023","unstructured":"Stewart BJ, Fergie M, Young MD, Jones C, Sachdeva A, Blain A, Bacon CM, Rand V, Ferdinand JR, James KR et al (2023) Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. Blood 141(19):2343\u20132358","journal-title":"Blood"},{"issue":"5","key":"4012_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114236","volume":"43","author":"C Lior","year":"2024","unstructured":"Lior C, Barki D, Halperin C, Iacobuzio-Donahue CA, Kelsen D, Shouval RS (2024) Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response. Cell Rep 43(5):114236","journal-title":"Cell Rep"},{"issue":"6","key":"4012_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ et al (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162(6):1229\u20131241","journal-title":"Cell"},{"issue":"2","key":"4012_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00251-016-0950-x","volume":"69","author":"SY Alomar","year":"2017","unstructured":"Alomar SY, Alkhuriji A, Trayhyrn P, Alhetheel A, Al-Jurayyan A, Mansour L (2017) Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer. Immunogenetics 69(2):69\u201376","journal-title":"Immunogenetics"},{"issue":"7","key":"4012_CR35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2174\/1566524023666230717162458","volume":"24","author":"A Canossi","year":"2024","unstructured":"Canossi A, Aureli A, Del Beato T, Novelli G, Buonomo O, Rossi P, Venditti A, Papola F, Sconocchia G (2024) Impact of HLA class I antigen, killer inhibitory receptor, and FCGR3A genotypes on breast cancer susceptibility and tumor stage. Curr Mol Med 24(7):920\u2013930","journal-title":"Curr Mol Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04012-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:49:06Z","timestamp":1745750946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04012-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4012"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04012-4","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"158"}}